Nagaoka et al., 1989 - Google Patents

Effects of idebenone on neurological deficits, local cerebral blood flow, and energy metabolism in rats with experimental cerebral ischemia

Nagaoka et al., 1989

Document ID
14681882684916908868
Author
Nagaoka A
Suno M
Shibota M
Kakihana M
Publication year
Publication venue
Archives of gerontology and geriatrics

External Links

Snippet

Improvement of energy metabolism in ischemic cerebral tissue benefits the therapy of occlusive cerebrovascular disorders. In the present study, the effects of 6-(10-hydroxydecyl)- 2, 3-dimethoxy-5-methyl-1, 4-benzoquinone (idebenone) on neurological signs, such as …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Similar Documents

Publication Publication Date Title
Nagaoka et al. Effects of idebenone on neurological deficits, local cerebral blood flow, and energy metabolism in rats with experimental cerebral ischemia
US5834466A (en) Method for protecting of heart by limiting metabolic and ionic abnormalities developed during ischemia, following ischemia or resulting from ischemia
Hoyt et al. Characterization of hydrogen peroxide toxicity in cultured rat forebrain neurons
Oates Aldose reductase, still a compelling target for diabetic neuropathy
Giugliano et al. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress?
Kannurpatti et al. Calcium sequestering ability of mitochondria modulates influx of calcium through glutamate receptor channel
Aureli et al. Effect of acetyl-L-carnitine on recovery of brain phosphorus metabolites and lactic acid level during reperfusion after cerebral ischemia in the rat—study by 13P-and 1H-NMR spectroscopy
Saling et al. Actions of juglone on energy metabolism in the rat liver
Wyss et al. Spontaneously hypertensive rats exhibit reduced hypothalamic noradrenergic input after NaCl loading.
US6034109A (en) Method for protection of heart by limiting metabolic and ionic abnormalities developed during ischemia following ischemia or resulting from ischemia
Gronow et al. Substrate support for renal functions during hypoxia in the perfused rat kidney
KR101350053B1 (en) Plant-based formulations for improving liver health
Stevens et al. Systematic studies on the effects of the NMDA receptor antagonist MK-801 on cerebral blood flow and responsivity, EEG, and blood-brain barrier following complete reversible cerebral ischemia
GB2198041A (en) Inhibiting alcohol addiction
Zimmermann et al. Pharmacological evidence that stimulation of central serotonergic pathways increases renin secretion
Kato et al. Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil
Winternitz et al. The role of the posterior hypothalamic area in the pathogenesis of hypertension in the spontaneously hypertensive rat
Köppen et al. Synergistic effect of nicotinamide and choline administration on extracellular choline levels in the brain.
Imai et al. NaH exchange is not operative under low-flow ischemic conditions
KR100616068B1 (en) Inhibitors of Diabetes Complications Containing Blueberry Extract
Savsani et al. Cardioprotective effect of flavonoids rich fraction of Premna mucronata on isoproterenol-induced myocardial infarction in Wistar rats
Bao et al. Poly (ADP-ribose) polymerase activation and brain edema formation by hemoglobin after intracerebral hemorrhage in rats
Williams et al. Study of aldose reductase inhibition in intact lenses by 13C nuclear magnetic resonance spectroscopy
Canga et al. Hypersensitivity to methoxamine in atria isolated from streptozotocin-induced diabetic rats
Navarro et al. CNS stimulation and PGE2 release. III. Pentamethylenetetrazole-induced seizures